시장보고서
상품코드
2035955

단순 헤르페스 바이러스(HSV) 중합효소 연쇄반응(PCR) 검사 시장 보고서(2026년)

Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Global Market Report 2026

발행일: | 리서치사: 구분자 The Business Research Company | 페이지 정보: 영문 250 Pages | 배송안내 : 2-10일 (영업일 기준)

    
    
    




■ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송일정은 문의해 주시기 바랍니다.

가격
PDF & Excel (Single User License) help
PDF & Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF·Excel 이용 범위와 동일합니다.
US $ 4,490 금액 안내 화살표 ₩ 6,791,000
PDF & Excel (Site License) help
PDF & Excel 보고서를 동일 기업의 동일 사업장 내의 모든 분이 이용할 수 있는 라이선스입니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF·Excel 이용 범위와 동일합니다.
US $ 6,490 금액 안내 화살표 ₩ 9,816,000
PDF & Excel (Enterprise License) help
PDF & Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF·Excel 이용 범위와 동일합니다.
US $ 8,490 금액 안내 화살표 ₩ 12,841,000
카드담기
※ 부가세 별도
한글목차
영문목차

단순 헤르페스 바이러스(HSV) 중합효소 연쇄반응(PCR) 검사 시장 규모는 최근 몇 년간 크게 성장했습니다. 이 시장은 2025년 11억 8,000만 달러에서 2026년에는 12억 8,000만 달러로, CAGR은 8.0%를 나타낼 전망입니다. 지난 수년간의 성장은 전 세계 HSV 감염 유병률 증가, 성병에 대한 인식 증가, 분자진단실험실의 확대, 핵산 증폭 검사의 보급 확대, 항바이러스 치료의 가용성 향상 등에 기인하는 것으로 보입니다.

.

단순 헤르페스 바이러스(HSV) 중합효소 연쇄반응(PCR) 검사 시장 규모는 향후 몇 년 동안 강력한 성장이 예상됩니다. CAGR 8.2%를 나타내 2030년에는 17억 5,000만 달러에 달할 것으로 예측됩니다. 예측 기간 동안 이러한 성장은 HSV 정기 검진 프로그램 도입 확대, 신속한 현장 분자 검사에 대한 수요 증가, 감염성 질환에 대한 정밀의료 접근법 확대, 신흥 시장에서의 의료 투자 증가, 다중 PCR 및 정량 PCR 플랫폼의 발전 등에 기인한 것으로 보입니다. 플랫폼의 기술적 진보에 기인한 것으로 분석됩니다. 예측 기간 동안 주요 동향으로는 HSV의 신속한 검출을 위한 실시간 PCR의 채택 확대, 신생아 및 생식기 HSV 사례의 조기 진단에 대한 수요 증가, 감별 진단을 위한 다중 PCR 분석의 사용 확대, 고감도 정량 PCR 검사의 보급, 자동화된 '검체에서 결과까지' 플랫폼의 통합 등이 있습니다. 플랫폼의 통합이 진행되고 있는 것을 들 수 있습니다.

감염증의 발생률 증가는 향후 몇 년 동안 단순 헤르페스 바이러스(HSV) 중합효소 연쇄반응(PCR) 검사 시장의 확대를 견인할 것으로 예측됩니다. 감염은 유해한 미생물이 체내에 침입하여 증식함으로써 발생하며, 질병을 유발할 수 있습니다. 도시화는 감염병 증가의 한 원인이 되고 있습니다. 도시에서는 인구밀도가 높아 사람과의 밀접한 접촉과 자원 공유를 통해 병원균의 전파가 가속화되기 때문입니다. 단순 헤르페스 바이러스(HSV) 중합효소 연쇄반응(PCR) 검사는 HSV DNA를 신속하고 정확하게 검출하여 조기 진단 및 치료를 가능하게 하고, 감염의 악화 및 타인에게 전염되는 것을 방지하는 데 도움이 됩니다. 예를 들어, 2023년 영국 정부 기관인 영국 보건안전청(UK Health Security Agency)은 영국 전역의 효모균 관련 혈류 감염 발생률이 2022년에 비해 4% 증가했다고 보고했습니다. 따라서 감염성 질환의 발생률 증가는 단순 헤르페스 바이러스(HSV) 중합효소 연쇄반응(PCR) 검사 시장의 성장을 가속하고 있습니다.

자주 묻는 질문

  • 단순 헤르페스 바이러스(HSV) 중합효소 연쇄반응(PCR) 검사 시장 규모는 어떻게 변화하고 있나요?
  • 단순 헤르페스 바이러스(HSV) 중합효소 연쇄반응(PCR) 검사 시장의 향후 성장 전망은 어떤가요?
  • 단순 헤르페스 바이러스(HSV) 중합효소 연쇄반응(PCR) 검사 시장의 성장은 어떤 요인에 기인하나요?
  • 단순 헤르페스 바이러스(HSV) 중합효소 연쇄반응(PCR) 검사의 기술적 발전은 어떤 방향으로 진행되고 있나요?
  • 감염증 발생률 증가는 단순 헤르페스 바이러스(HSV) 중합효소 연쇄반응(PCR) 검사 시장에 어떤 영향을 미치나요?

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 공급망 분석

제4장 세계 시장 동향과 전략

제5장 최종 이용 산업 시장 분석

제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의의 공급망에 대한 영향, 코로나 팬데믹이 시장에 미치는 영향을 포함한 거시경제 시나리오

제7장 세계 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석

제8장 총 잠재 시장 규모

제9장 시장 세분화

제10장 지역 및 국가별 분석

제11장 아시아태평양 시장

제12장 중국 시장

제13장 인도 시장

제14장 일본 시장

제15장 호주 시장

제16장 인도네시아 시장

제17장 한국 시장

제18장 대만 시장

제19장 동남아시아 시장

제20장 서유럽 시장

제21장 영국 시장

제22장 독일 시장

제23장 프랑스 시장

제24장 이탈리아 시장

제25장 스페인 시장

제26장 동유럽 시장

제27장 러시아 시장

제28장 북미 시장

제29장 미국 시장

제30장 캐나다 시장

제31장 남아메리카 시장

제32장 브라질 시장

제33장 중동 시장

제34장 아프리카 시장

제35장 시장 규제 상황과 투자환경

제36장 경쟁 구도와 기업 개요

제37장 기타 주요 기업 및 혁신 기업

제38장 세계 시장 경쟁 벤치마킹과 대시보드

제39장 주목받는 스타트업

제40장 주요 인수합병(M&A)

제41장 시장 잠재력이 높은 국가, 부문, 전략

제42장 부록

KTH 26.05.18

Herpes simplex virus (HSV) polymerase chain reaction (PCR) testing is a molecular diagnostic technique that detects HSV DNA in clinical specimens such as blood, swabs, or cerebrospinal fluid. It provides rapid, highly sensitive, and specific identification of HSV infections, including genital, oral, or neonatal cases. This testing supports early diagnosis, guides antiviral therapy, and helps prevent transmission of the infection.

The key test types of herpes simplex virus (HSV) polymerase chain reaction (PCR) testing include polymerase chain reaction testing, serology testing, and culture testing. PCR testing amplifies and detects specific DNA or RNA sequences to identify pathogens or genetic material with high sensitivity and accuracy. Product types include instruments, reagents and kits, and software, used with sample types such as vesicular swabs or fluid samples, cerebrospinal fluid samples, and blood or serum samples. Applications include clinical diagnostics, research, blood screening, and others, serving hospitals and clinics, diagnostic laboratories, research institutes, and other end users.

Tariffs on imported PCR instruments, reagents, and molecular diagnostic components are influencing the HSV PCR testing market by increasing procurement and operational costs for hospitals and diagnostic laboratories. Segments such as instruments and reagents and kits are most affected, particularly in regions reliant on imported diagnostic systems, including parts of Asia-Pacific, Latin America, and Africa. Higher costs may limit accessibility in low-resource settings; however, tariffs are also encouraging domestic production of PCR kits and localized manufacturing of diagnostic equipment, supporting supply chain resilience and regional innovation over the long term.

The herpes simplex virus (HSV) polymerase chain reaction (PCR) testing market research report is one of a series of new reports from The Business Research Company that provides herpes simplex virus (HSV) polymerase chain reaction (PCR) testing market statistics, including herpes simplex virus (HSV) polymerase chain reaction (PCR) testing industry global market size, regional shares, competitors with a herpes simplex virus (HSV) polymerase chain reaction (PCR) testing market share, detailed herpes simplex virus (HSV) polymerase chain reaction (PCR) testing market segments, market trends and opportunities, and any further data you may need to thrive in the herpes simplex virus (HSV) polymerase chain reaction (PCR) testing industry. This herpes simplex virus (HSV) polymerase chain reaction (PCR) testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The herpes simplex virus (HSV) polymerase chain reaction (PCR) testing market size has grown strongly in recent years. It will grow from $1.18 billion in 2025 to $1.28 billion in 2026 at a compound annual growth rate (CAGR) of 8.0%. The growth in the historic period can be attributed to rising global prevalence of hsv infections, increasing awareness of sexually transmitted infections, expansion of molecular diagnostic laboratories, growing adoption of nucleic acid amplification tests, increasing availability of antiviral therapies

.

The herpes simplex virus (HSV) polymerase chain reaction (PCR) testing market size is expected to see strong growth in the next few years. It will grow to $1.75 billion in 2030 at a compound annual growth rate (CAGR) of 8.2%. The growth in the forecast period can be attributed to growing implementation of routine hsv screening programs, rising demand for rapid point-of-care molecular testing, expansion of precision medicine approaches in infectious diseases, increasing healthcare investments in emerging markets, technological advancements in multiplex and quantitative pcr platforms. Major trends in the forecast period include increasing adoption of real-time pcr for rapid hsv detection, rising demand for early diagnosis in neonatal and genital hsv cases, growing use of multiplex pcr assays for differential diagnosis, expansion of high-sensitivity quantitative pcr testing, increasing integration of automated sample-to-result platforms.

The rising occurrence of infections is anticipated to drive the expansion of the herpes simplex virus (HSV) polymerase chain reaction (PCR) testing market in the coming years. Infections occur when harmful microorganisms invade and grow within the body, potentially causing illness. Urbanization contributes to the increase in infections, as higher population densities in cities promote faster transmission of pathogens through close human contact and shared resources. Herpes simplex virus (HSV) polymerase chain reaction (PCR) testing aids by rapidly and accurately detecting HSV DNA, facilitating early diagnosis and treatment, which prevents the infection from worsening or spreading to others. For example, in 2023, the UK Health Security Agency, a government body in the UK, reported that the rate of yeast-related bloodstream infections across England increased by 4% compared to 2022. Hence, the rising occurrence of infections is fueling the growth of the herpes simplex virus (HSV) polymerase chain reaction (PCR) testing market.

Leading companies operating in the herpes simplex virus (HSV) polymerase chain reaction (PCR) testing market are focusing on developing innovative solutions such as point-of-care molecular diagnostics to enable rapid, accurate, and decentralized detection of HSV infections for improved patient management. Point-of-care molecular diagnostics refers to tests that detect pathogens rapidly and accurately at the site of patient care without the need for a central laboratory. For example, in January 2023, Molbio Diagnostics Pvt. Ltd., an India-based medical technology company, launched a Truenat HSV 1/2 chip-based RT-PCR test for diagnosing herpes simplex virus types 1 and 2. This portable, point-of-care assay delivers results in under one hour from genital swabs or cerebrospinal fluid (CSF) using the battery-operated Truelab platform, requires no additional equipment, and holds central drugs standard control organisation (CDSCO) approval in India. It supports rapid detection of active herpes simplex virus (HSV) infections to boost awareness and early treatment amid rising cases.

In May 2024, Bruker Corporation, a US-based scientific instruments and diagnostics company, acquired ELITech Group for an undisclosed sum. With this acquisition, Bruker seeks to broaden its footprint in polymerase chain reaction (PCR) molecular diagnostics and enhance its clinical laboratory diagnostic offerings by utilizing ELITech Group's molecular diagnostic systems, infectious disease assays, and microbiology solutions, thereby strengthening Bruker's market presence and service capabilities for clinical laboratories. ELITech Group is a France-based molecular diagnostic company providing herpes simplex virus (HSV) PCR testing solutions.

Major companies operating in the herpes simplex virus (HSV) polymerase chain reaction (PCR) testing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Becton, Dickinson Company, Quest Diagnostics Incorporated, Hologic Inc., bioMerieux SA, Bio-Rad Laboratories Inc., QIAGEN N.V., DiaSorin S.p.A., Promega Corporation, Meridian Bioscience Inc., Seegene Inc., BioPerfectus Technologies Co. Ltd., altona Diagnostics GmbH, Xi'an Tianlong Science & Technology Co. Ltd., 3B BlackBio Dx Limited, GeneProof s.r.o., Primerdesign Ltd., BioHelix Corporation.

North America was the largest region in the herpes simplex virus (HSV) polymerase chain reaction (PCR) testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the herpes simplex virus (HSV) polymerase chain reaction (PCR) testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the herpes simplex virus (HSV) polymerase chain reaction (PCR) testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The herpes simplex virus (HSV) polymerase chain reaction (PCR) testing market consists of revenues earned by entities by providing services such as quantitative viral load analysis, confirmation of suspected cases, prenatal and neonatal screening, and monitoring of treatment efficacy. The market value includes the value of related goods sold by the service provider or included within the service offering. The herpes simplex virus (HSV) polymerase chain reaction (PCR) testing market also includes sales of control and calibration materials, viral transport media, swabs and sample collection devices, automated nucleic acid extraction systems, microfluidic cartridges, and laboratory automation accessories. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses herpes simplex virus (hsv) polymerase chain reaction (pcr) testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for herpes simplex virus (hsv) polymerase chain reaction (pcr) testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The herpes simplex virus (hsv) polymerase chain reaction (pcr) testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Test Type: Polymerase Chain Reaction Testing; Serology Testing; Culture Testing
  • 2) By Product Type: Instruments; Reagents And Kits; Software
  • 3) By Sample Type: Vesicular Swabs or Fluid Samples; Cerebrospinal Fluid Samples; Blood or Serum Samples
  • 4) By Application: Clinical Diagnostics; Research; Blood Screening; Other Applications
  • 5) By End User: Hospitals And Clinics; Diagnostic Laboratories; Research Institutes; Other End Users
  • Subsegments:
  • 1) By Polymerase Chain Reaction Testing: Real Time Polymerase Chain Reaction; Nested Polymerase Chain Reaction; Multiplex Polymerase Chain Reaction; Quantitative Polymerase Chain Reaction
  • 2) By Serology Testing: IgM Antibody Testing; IgG Antibody Testing; Western Blot Testing; Enzyme Linked Immunosorbent Assay
  • 3) By Culture Testing: Cell Culture Isolation; Plaque Assay Culture; Shell Vial Culture; Tissue Culture Infection Assay
  • Companies Mentioned: F. Hoffmann-La Roche Ltd.; Thermo Fisher Scientific Inc.; Abbott Laboratories; Danaher Corporation; Becton; Dickinson Company; Quest Diagnostics Incorporated; Hologic Inc.; bioMerieux SA; Bio-Rad Laboratories Inc.; QIAGEN N.V.; DiaSorin S.p.A.; Promega Corporation; Meridian Bioscience Inc.; Seegene Inc.; BioPerfectus Technologies Co. Ltd.; altona Diagnostics GmbH; Xi'an Tianlong Science & Technology Co. Ltd.; 3B BlackBio Dx Limited; GeneProof s.r.o.; Primerdesign Ltd.; BioHelix Corporation.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Biotechnology, Genomics & Precision Medicine
    • 4.1.2 Artificial Intelligence & Autonomous Intelligence
    • 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.4 Industry 4.0 & Intelligent Manufacturing
    • 4.1.5 Internet of Things (IoT), Smart Infrastructure & Connected Ecosystems
  • 4.2. Major Trends
    • 4.2.1 Increasing Adoption of Real-Time PCR for Rapid HSV Detection
    • 4.2.2 Rising Demand for Early Diagnosis in Neonatal and Genital HSV Cases
    • 4.2.3 Growing Use of Multiplex PCR Assays for Differential Diagnosis
    • 4.2.4 Expansion of High-Sensitivity Quantitative PCR Testing
    • 4.2.5 Increasing Integration of Automated Sample-to-Result Platforms

5. Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Market Analysis Of End Use Industries

  • 5.1 Hospitals And Clinics
  • 5.2 Diagnostic Laboratories
  • 5.3 Research Institutes
  • 5.4 Public Health Laboratories
  • 5.5 Blood Banks

6. Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Market Segmentation

  • 9.1. Global Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Polymerase Chain Reaction Testing, Serology Testing, Culture Testing
  • 9.2. Global Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Instruments, Reagents And Kits, Software
  • 9.3. Global Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Sample Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Vesicular Swabs or Fluid Samples, Cerebrospinal Fluid Samples, Blood or Serum Samples
  • 9.4. Global Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Clinical Diagnostics, Research, Blood Screening, Other Applications
  • 9.5. Global Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hospitals And Clinics, Diagnostic Laboratories, Research Institutes, Other End Users
  • 9.6. Global Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Market, Sub-Segmentation Of Polymerase Chain Reaction Testing, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Real Time Polymerase Chain Reaction, Nested Polymerase Chain Reaction, Multiplex Polymerase Chain Reaction, Quantitative Polymerase Chain Reaction
  • 9.7. Global Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Market, Sub-Segmentation Of Serology Testing, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • IgM Antibody Testing, IgG Antibody Testing, Western Blot Testing, Enzyme Linked Immunosorbent Assay
  • 9.8. Global Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Market, Sub-Segmentation Of Culture Testing, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Cell Culture Isolation, Plaque Assay Culture, Shell Vial Culture, Tissue Culture Infection Assay

10. Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Market Regional And Country Analysis

  • 10.1. Global Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Market

  • 11.1. Asia-Pacific Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Test Type, Segmentation By Product Type, Segmentation By Sample Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Market

  • 12.1. China Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Test Type, Segmentation By Product Type, Segmentation By Sample Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Market

  • 13.1. India Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Test Type, Segmentation By Product Type, Segmentation By Sample Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Market

  • 14.1. Japan Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Test Type, Segmentation By Product Type, Segmentation By Sample Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Market

  • 15.1. Australia Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Test Type, Segmentation By Product Type, Segmentation By Sample Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Market

  • 16.1. Indonesia Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Test Type, Segmentation By Product Type, Segmentation By Sample Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Market

  • 17.1. South Korea Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Test Type, Segmentation By Product Type, Segmentation By Sample Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Market

  • 18.1. Taiwan Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Test Type, Segmentation By Product Type, Segmentation By Sample Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Market

  • 19.1. South East Asia Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Test Type, Segmentation By Product Type, Segmentation By Sample Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Market

  • 20.1. Western Europe Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Test Type, Segmentation By Product Type, Segmentation By Sample Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Market

  • 21.1. UK Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Test Type, Segmentation By Product Type, Segmentation By Sample Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Market

  • 22.1. Germany Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Test Type, Segmentation By Product Type, Segmentation By Sample Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Market

  • 23.1. France Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Test Type, Segmentation By Product Type, Segmentation By Sample Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Market

  • 24.1. Italy Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Test Type, Segmentation By Product Type, Segmentation By Sample Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Market

  • 25.1. Spain Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Test Type, Segmentation By Product Type, Segmentation By Sample Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Market

  • 26.1. Eastern Europe Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Test Type, Segmentation By Product Type, Segmentation By Sample Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Market

  • 27.1. Russia Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Test Type, Segmentation By Product Type, Segmentation By Sample Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Market

  • 28.1. North America Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Test Type, Segmentation By Product Type, Segmentation By Sample Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Market

  • 29.1. USA Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Test Type, Segmentation By Product Type, Segmentation By Sample Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Market

  • 30.1. Canada Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Test Type, Segmentation By Product Type, Segmentation By Sample Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Market

  • 31.1. South America Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Test Type, Segmentation By Product Type, Segmentation By Sample Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Market

  • 32.1. Brazil Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Test Type, Segmentation By Product Type, Segmentation By Sample Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Market

  • 33.1. Middle East Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Test Type, Segmentation By Product Type, Segmentation By Sample Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Market

  • 34.1. Africa Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Test Type, Segmentation By Product Type, Segmentation By Sample Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Market Regulatory and Investment Landscape

36. Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Market Competitive Landscape And Company Profiles

  • 36.1. Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Market Company Profiles
    • 36.3.1. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Becton Overview, Products and Services, Strategy and Financial Analysis

37. Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Market Other Major And Innovative Companies

  • Dickinson Company, Quest Diagnostics Incorporated, Hologic Inc., bioMerieux SA, Bio-Rad Laboratories Inc., QIAGEN N.V., DiaSorin S.p.A., Promega Corporation, Meridian Bioscience Inc., Seegene Inc., BioPerfectus Technologies Co. Ltd., altona Diagnostics GmbH, Xi'an Tianlong Science & Technology Co. Ltd., 3B BlackBio Dx Limited, GeneProof s.r.o.

38. Global Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Market Competitive Benchmarking And Dashboard

39. Upcoming Startups in the Market

40. Key Mergers And Acquisitions In The Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Market

41. Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Market High Potential Countries, Segments and Strategies

  • 41.1 Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Market In 2030 - Countries Offering Most New Opportunities
  • 41.2 Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Market In 2030 - Segments Offering Most New Opportunities
  • 41.3 Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Market In 2030 - Growth Strategies
    • 41.3.1 Market Trend Based Strategies
    • 41.3.2 Competitor Strategies

42. Appendix

  • 42.1. Abbreviations
  • 42.2. Currencies
  • 42.3. Historic And Forecast Inflation Rates
  • 42.4. Research Inquiries
  • 42.5. The Business Research Company
  • 42.6. Copyright And Disclaimer
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제
문의
원하시는 정보를
찾아 드릴까요?
문의주시면 필요한 정보를
신속하게 찾아드릴게요.
02-2025-2992
kr-info@giikorea.co.kr
문의하기